HomeAI · summaries
Storia in 4 fonti
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
US tariff threats lead to a 1.4% drop in Nifty Pharma, with Lupin and Auropharma experiencing significant declines.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028
Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption…
- ·
thehindubusinessline.com
Nifty opens lower; pharma stocks bleed, auto sector shines
